These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 33147451)

  • 1. HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon.
    Miner JJ; Platt DJ; Ghaznavi CM; Chandra P; Santeford A; Menos AM; Dong Z; Wang ER; Qian W; Karozichian ES; Philips JA; Apte RS
    Cell Rep; 2020 Nov; 33(5):108339. PubMed ID: 33147451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
    Stanifer ML; Kee C; Cortese M; Zumaran CM; Triana S; Mukenhirn M; Kraeusslich HG; Alexandrov T; Bartenschlager R; Boulant S
    Cell Rep; 2020 Jul; 32(1):107863. PubMed ID: 32610043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
    Park A; Iwasaki A
    Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
    Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
    Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
    Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
    Pique-Regi R; Romero R; Tarca AL; Luca F; Xu Y; Alazizi A; Leng Y; Hsu CD; Gomez-Lopez N
    Elife; 2020 Jul; 9():. PubMed ID: 32662421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.
    O'Brien TR; Thomas DL; Jackson SS; Prokunina-Olsson L; Donnelly RP; Hartmann R
    Clin Infect Dis; 2020 Sep; 71(6):1410-1412. PubMed ID: 32301957
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-stimulated gene 15 (ISG15) restricts Zika virus replication in primary human corneal epithelial cells.
    Singh PK; Singh S; Farr D; Kumar A
    Ocul Surf; 2019 Jul; 17(3):551-559. PubMed ID: 30905842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A STING-dependent innate-sensing pathway mediates resistance to corneal HSV-1 infection via upregulation of the antiviral effector tetherin.
    Royer DJ; Carr DJ
    Mucosal Immunol; 2016 Jul; 9(4):1065-75. PubMed ID: 26627457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.
    Parker ZM; Pasieka TJ; Parker GA; Leib DA
    J Virol; 2016 Dec; 90(23):10789-10799. PubMed ID: 27681121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology.
    Philip DT; Goins NM; Catanzaro NJ; Misumi I; Whitmire JK; Atkins HM; Lazear HM
    mBio; 2024 Apr; 15(4):e0262323. PubMed ID: 38426749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
    Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika Virus and Host Interactions: From the Bench to the Bedside and Beyond.
    Limonta D; Hobman TC
    Cells; 2020 Nov; 9(11):. PubMed ID: 33198165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III interferons disrupt the lung epithelial barrier upon viral recognition.
    Broggi A; Ghosh S; Sposito B; Spreafico R; Balzarini F; Lo Cascio A; Clementi N; De Santis M; Mancini N; Granucci F; Zanoni I
    Science; 2020 Aug; 369(6504):706-712. PubMed ID: 32527925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.